Prevalence of HI V-related thrombocytopenia among clients at Mbarara Regional Referral Hospital, Mbarara, southwestern Uganda
![Thumbnail](/xmlui/bitstream/handle/123456789/2338/Prevalence%20of%20HIV-related%20thrombocytopenia%20among%20clients%20at%20Mbarara%20Regional%20Referral%20Hospital%2c%20Mbarara%2c%20southwestern%20Uganda.pdf.jpg?sequence=4&isAllowed=y)
View/ Open
Date
2015-04-10Author
Taremwa, Ivan M
Muyindike, Winnie R
Muwanguzi, Enoch
II, Yap Boum
Natukunda, Bernard
Metadata
Show full item recordAbstract
Aims/objectives: We aimed to determine the prevalence and correlates of thrombocytopenia among people living with human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) and to assess occurrence of antiplatelet antibodies, among thrombocytopenic HIV clients at Mbarara Regional Referral Hospital, southwestern Uganda.
Materials and methods: This was a retrospective review of hematologic results at enroll¬ment to HIV care from 2005 to 2013. The prevalence and correlates of thrombocytopenia were estimated based on the Immune Suppressed Syndrome (ISS) Clinic electronic database. A cross-sectional study determined the occurrence of antiplatelet antibodies, using the mono¬clonal antibody-specific immobilization of platelet antigens (MAIPA) technique.
Results: We reviewed 15,030 client records. The median age was 35.0 (range 18–78; interquartile range [IQR] 28–42) years, and there were 63.2% (n=9,500) females. The overall prevalence of thrombocytopenia was 17.4% (95% confidence interval [CI]: 16.8%–18.0%). The prevalence of thrombocytopenia was 17.8% (95% CI: 17.1%–18.4%) among antiretrovi¬ral therapy (ART)-naïve clients (n=2,675) and was 13.0% (95% CI: 0.3%–21.9%) for clients who were on ART (n=6). The study found a significant association between thrombocytopenia and other cytopenias, CD4 counts, ART, and deteriorating HIV stage (P,0.05). Two of the 40 participants (5.0%) had antiplatelet antibodies.
Conclusion: This study has showed a high prevalence of HIV-related thrombocytopenia. Antiplatelet antibodies were found in 5.0% of HIV-infected thrombocytopenic participants. Our study shows a significant association of thrombocytopenia burden in a high-HIV study population (Southwest Uganda); therefore, there is need to monitor platelet counts and initiate platelet transfusion in our blood banking practices, to avert possible risks of bleeding
Collections
- Research Articles [109]